LB Pharmaceuticals Inc

LBRXNASDAQHealthcareBiotechnology

$36.74- (-)1Y +135.32%

As of Oct 16, 2026 close

Market cap: $1.11B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $14.32$50.16
Volume (live): -
Avg. volume (3M): 405.62K

LB Pharmaceuticals Inc (LBRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for LB Pharmaceuticals Inc stock.

Analyst Consensus Rating

Investment consensus from 8 professional research analysts

Consensus Rating

Buy

Based on 8 unique analysts

(10 total ratings in last 90 days)

Medium Confidence∞:1 Buy/Sell

Average Price Target

$56.75

+54.46% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest LBRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 5, 2026	Boobalan Pachaiyappan	Roth MKM	Downgrades	Hold	$37.00 → $35.00 −2.00 (−5.4%)
Oct 2, 2026	Ami Fadia	Needham	Initiates	Buy	$68.00
Aug 24, 2026	Ram Selvaraju	HC Wainwright	Reiterates	Buy	$45.00 → $60.00 +15.00 (+33.3%)
Aug 21, 2026	Kaveri Pohlman	Clear Street	Initiates Coverage	Buy	$45.00 → $69.00 +24.00 (+53.3%)
Aug 20, 2026	Kaveri Pohlman	Clear Street	Reiterates	Buy	$45.00 → $69.00 +24.00 (+53.3%)
Aug 13, 2026	Paul Matteis	Stifel Nicolaus	Maintains	Buy	$40.00 → $53.00 +13.00 (+32.5%)
Aug 12, 2026	Adam Vogel	Craig-Hallum	Maintains	Buy	$36.00 → $45.00 +9.00 (+25.0%)
Aug 3, 2026	Yasmeen Rahimi	Piper Sandler	Maintains	Buy	$78.00
Jul 21, 2026	Malcolm Hoffman	BMO Capital	Initiates	Buy	$46.00
Jul 20, 2026	Malcolm Hoffman	BMO Capital	Initiates	Buy	$46.00

Boobalan Pachaiyappan

Roth MKM

HoldDowngrades

$37.00 → $35.00

Oct 5

Ami Fadia

Needham

BuyInitiates

$68.00

Oct 2

Ram Selvaraju

HC Wainwright

BuyReiterates

$45.00 → $60.00

Aug 24

Kaveri Pohlman

Clear Street

BuyInitiates Coverage

$45.00 → $69.00

Aug 21

Kaveri Pohlman

Clear Street

BuyReiterates

$45.00 → $69.00

Aug 20

Paul Matteis

Stifel Nicolaus

BuyMaintains

$40.00 → $53.00

Aug 13

Adam Vogel

Craig-Hallum

BuyMaintains

$36.00 → $45.00

Aug 12

Yasmeen Rahimi

Piper Sandler

BuyMaintains

$78.00

Aug 3

Malcolm Hoffman

BMO Capital

BuyInitiates

$46.00

Jul 21

Malcolm Hoffman

BMO Capital

BuyInitiates

$46.00

Jul 20

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for LBRX?

The analyst consensus rating for LBRX is Buy, based on the latest ratings from 8 analysts over the last 90 days.

What is the average price target for LBRX?

The average 12-month price target for LBRX is $56.75, representing an upside of 54.5% from the Oct 16, 2026 close of $36.74.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.